Growth Metrics

Rigel Pharmaceuticals (RIGL) Net Income towards Common Stockholders Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -10.84%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 26.38%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -46.86%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 13.80%
7 Evaxion A 62.56 Bn 62.54 Bn - 34.98%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -3.84%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 47.10%
10 Rigel Pharmaceuticals 551.62 Mn 404.94 Mn 54.21 Mn 38.20%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 38.20%
Dec 31, 2025 476.24%
Sep 30, 2025 51.33%
Jun 30, 2025 85.84%
Mar 31, 2025 34.20%
Dec 31, 2024 38.11%
Sep 30, 2024 37.38%
Jun 30, 2024 57.92%
Mar 31, 2024 -30.23%
Dec 31, 2023 26.79%
Sep 30, 2023 26.22%
Jun 30, 2023 27.85%
Mar 31, 2023 -38.16%
Dec 31, 2022 27.68%
Sep 30, 2022 -18.33%
Jun 30, 2022 13.17%
Mar 31, 2022 -15.97%
Dec 31, 2021 -108.02%
Sep 30, 2021 4.11%
Jun 30, 2021 18.53%
Mar 31, 2021 53.54%
Dec 31, 2020 9.40%
Sep 30, 2020 7.07%
Jun 30, 2020 2.81%
Mar 31, 2020 50.18%
Dec 31, 2019 -3.33%
Sep 30, 2019 20.22%
Jun 30, 2019 -15.04%
Mar 31, 2019 -0.26%
Dec 31, 2018 31.12%
Sep 30, 2018 -52.72%
Jun 30, 2018 -22.47%
Mar 31, 2018 -10.26%
Dec 31, 2017 -5.12%
Sep 30, 2017 5.52%
Jun 30, 2017 8.98%
Mar 31, 2017 11.78%
Dec 31, 2016 2.58%
Sep 30, 2016 1.70%
Jun 30, 2016 15.92%
Mar 31, 2016 11.94%
Dec 31, 2015 20.73%
Sep 30, 2015 36.00%
Jun 30, 2015 17.46%
Mar 31, 2015 7.75%
Dec 31, 2014 4.77%
Sep 30, 2014 -5.31%
Jun 30, 2014 -5.74%
Mar 31, 2014 -2.38%
Dec 31, 2013 0.74%
Sep 30, 2013 -35.22%
Jun 30, 2013 -41.65%